flecainide / Generic mfg.  >>  Phase 3
Welcome,         Profile    Billing    Logout  

8 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
flecainide / Generic mfg.
Stop-AF, NCT00523978: A Clinical Study of the Arctic Front Cryoablation Balloon for the Treatment of Paroxysmal Atrial Fibrillation

Completed
3
245
Canada, US
Arctic Front® Cryoablation Catheter, Arctic Front® Cardiac CryoAblation Catheter System, Artic Front®, Flecainide or Sotalol or Propafenone, Tambocor, Sotalol, Propafenone
Medtronic Cardiac Rhythm and Heart Failure, Medtronic
Paroxysmal Atrial Fibrillation
08/10
07/11
NCT00392106: High Intensity Focused Ultrasound (HIFU) Ablation System Study

Suspended
3
240
US, Europe
propafenone, Rhyhmol, flecainide, Tambocor, dofetilide, Tikosyn, sotolol, Betapace, Pulmonary vein ablation, Left atrial ablation, Amiodarone, Pacerone
ProRhythm, Inc.
Atrial Fibrillation
12/10
06/11
PACIFIC, NCT00589303: AV Node Ablation and Pacemaker Therapy Compared to Drug Therapy for Atrial Fibrillation - Pilot Study

Terminated
3
27
US, Canada
FDA approved rate and rhythm control drugs, Lopressor, Toprol XL, Tenormin, Coreg, Isoptin, Verelan, Verelan PM, Calan, Bosoptin, Covera-HS, Cardizem, Pronestyl, Norpace, Rythmol, Betapace, Tikosyn, Cordarone, Pacerone, AV Node ablation and device implant
Mayo Clinic, Medtronic
Atrial Fibrillation, Heart Failure
07/11
07/11
2021-004865-11: Not applicable

Ongoing
3
110
Europe
FLECARDIA, Ranexa, Solution for injection/infusion, Prolonged-release tablet, FLECARDIA, Ranexa
Win Medica Pharmaceuticals S.A., Win Medica Pharmaceuticals S.A.
Restoration of sinus rhythm in patients with recent AF onset Αποκατάσταση του φλεβοκομβικού ρυθμού σε ασθενείς με ΚΜ προσφάτου ενάρξεως, Restoration of sinus rhythm in patients with recent AF onset Αποκατάσταση του φλεβοκομβικού ρυθμού σε ασθενείς με ΚΜ προσφάτου ενάρξεως, Diseases [C] - Cardiovascular Diseases [C14]
 
 
2021-006614-37: First-line catheter ablation for early treatment of Persistent (ongoing unless cardioverted) Atrial Fibrillation (AF) – a randomized study comparing isolation of pulmonary veins triggering AF using a Cryoballoon versus antiarrhythmic medication. Kryoablation som förstahandsval för tidig behandling av persisterande (fortgående såvida inte elektrisk eller medicinsk konvertering ges) förmaksflimmer - en randomiserad studie som jämför lungvensisolering med rytmstabiliserande läkemedel.

Ongoing
3
220
Europe
Tablet, tambocor, multaq, rytmonorm, sotalol
Carina Blomström Lundqvist, Swedish Research Council, Familjen Erling-Perssons Stiftelse, Swedish Heart and Lung Foundation
Persistent symptomatic atrial fibrillation Persisterande symptomatiskt förmaksflimmer, Irregular heart rhythm proved to be persistent symptomatic atrial fibrillation (chaotic rhythm in the hearts atria) that requires electrical or medical cardioversion to normal rhythm. Oregelbunden hjärtrytm som beror på ihållande förmaksflimmer som kräver medicinsk eller elektrisk konvertering för omslag till sinus rytm., Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02]
 
 
RESTORE-1, NCT05039359: Flecainide Acetate Inhalation Solution for Cardioversion of Recent-Onset, Symptomatic Atrial Fibrillation

Terminated
3
54
Europe, US, RoW
FlecIH-103
InCarda Therapeutics, Inc.
Paroxysmal Atrial Fibrillation
05/23
05/23
FLECA-ED, NCT05549752: Flecainide Versus Amiodarone in the Cardioversion of Paroxysmal Atrial Fibrillation at the Emergency Department, in Patients With Coronary Artery Disease Without Residual Ischemia

Recruiting
3
200
Europe
Flecainide Injectable Solution, Amiodarone Injectable Solution
Hippocration General Hospital, Win Medica, Pharmassist Ltd
Atrial Fibrillation Paroxysmal, Coronary Artery Disease Without Residual Ischemia
10/24
11/24
PRESERVE-SR, NCT03162120: Comparison of Effectiveness of Ranolazine Plus Metoprolol Combination vs. FlecainidE pluS Metoprolol Combination in ATrial Fibrillation Recurrences FOllowing PhaRmacological or Electrical CardioverSion of AtRial Fibrillation

Withdrawn
2/3
0
NA
Ranolazine plus Metoprolol Combination, RM group, FlecainidE pluS Metoprolol Combination, FM group
Elpen Pharmaceutical Co. Inc.
Atrial Fibrillation, Recurrence
12/18
12/18

Download Options